OVERNIGHT U.S. STOCK MOVERS
Contact Your Financial Adviser MONEY MAKING MC
Contact Your Financial Adviser MONEY MAKING MC
Signature Bank/New York
(SBNY +0.95%) was upgraded to 'Strong Buy' from 'Outperform' at Raymond James
with a 12-month price target of $162.
Abbott Laboratories (ABT
+0.96%) was upgraded to 'Buy' from 'Hold' at Edward Jones.
Imperva (IMPV +0.27%)
rallied over 9% in after-hours trading after Elliott Associates disclosed a
9.8% stake in Imperva and said it began a dialogue with management and board
regarding strategic and operational opportunities.
Knight Transportation (KNX
+3.53%) was downgraded to 'Neutral' from 'Buy' at Bank of America/Merrill
Lynch.
Prologis (PLD +0.06%) was
downgraded to 'Hold' from 'Buy' at Deutsche Bank.
Kirby Corp. (KEX +0.90%)
was downgraded to 'Neutral' from 'Outperform' at Credit Suisse.
CNOOC Ltd. (CEO +2.55%) was
upgraded to 'Buy' from 'Neutral' at UBS.
Paratek Pharmaceuticals
(PRTK -2.59%) slid over 2% in after-hours trading after it proposed an offering
of 3.75 million shares of common stock.
Sunrun (RUN +2.66%) gained
over 1% in after-hours trading after it was rated a new 'Outperform' at
Oppenheimer,
American Superconductor
(AMSC +1.21%) was rated a new 'Outperform' at Oppenheimer with an 18-month
price target of $12.
Opko Health (OPK +1.55%)
rose nearly 4% in after-hours trading after a FDA approved-drugs website
indicated approval for Opko's Rayaldee drug came on June 17.
Werner (WERN +1.36%)
dropped over 9% in after-hours trading after it warned that Q2 EPS may be only
21 cents-35 cents, below consensus of 40 cents, due to "sluggish"
freight market conditions, driver pay and contractor cost increases.
Scynexis (SCYX +6.85%)
tumbled over 11% in after-hours trading after it announced it will launch a
public offering of common stock and warrants.
No comments:
Post a Comment